BackBioceres Crop Solutions Overview

Bioceres Crop Solutions Other Current Liabilities

Latest other current liabilities for BIOX: $38M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$37.80M
244.07% YoYΔ $26.81M vs prior year quarter

Peer average

Loading

Bioceres Crop Solutions Other Current Liabilities History

Loading

Bioceres Crop Solutions vs. peers: Other Current Liabilities Comparison

Loading

Bioceres Crop Solutions Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bioceres Crop Solutions (BIOX) FAQ

Bioceres Crop Solutions posts a other current liabilities of $38M as of March 2026. That compares with $11M in the prior-year period — up 244.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bioceres Crop Solutions's other current liabilities was $11M. The latest reading is $38M — a 244.1% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Bioceres Crop Solutions's financial statement story. At $38M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BIOX's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bioceres Crop Solutions's other metric pages and overview cover the third.

Judging Bioceres Crop Solutions against Industrials peers is usually better than using a market-wide rule of thumb. Business models inside Industrials are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $38M here, then scan peer and history charts to see if the gap is persistent.